dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
xolair 150 mg s.c. vial
زولير 150مجم فيال للحقن تحت الجلد
omalizumab · 150mg
5433EGP
Available
Active ingredient
omalizumab
Strength
150mg
Form
vial
Manufacturer
novartis
Route
injection

Uses

Used for moderate to severe allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and selected IgE-mediated food allergies.

Do not use if

Severe hypersensitivity to omalizumab or any component of the formulation.

Side effects

Injection-site reactions, headache, arthralgia, fatigue, and hypersensitivity reactions may occur.

Warnings

Anaphylaxis may occur even after long-term treatment. Patients should be monitored appropriately.

How it works

Anti-IgE monoclonal antibody that reduces allergic inflammatory responses by binding free IgE.

Storage

Store refrigerated at 2°C to 8°C and protect from direct sunlight.